INTERNATIONAL BIOSIMILARS SUMMIT

The biosimilars industry landscape is rapidly evolving and creating significant revenue opportunities for companies that can successfully develop and market them. According to the GBI research global biosimilars market value could hit $55 billion by 2020 from its current value of $20 billion, which clearly shows the industries trending business opportunities. Thus, this summit is one of the most important opportunities, where you will explore your business potential in this trending industry. It is particularly important for the fields key opinion leaders, most exciting new-comers and others to come together to discuss and learn about the up-to-the-minute trends of biosimilars, commercial strategy, effective planning and strategies for biosimilars future development, etc. It will bring together experts from all levels of the value chain to analyze and tackle the latest and greatest opportunities in the biosimilars industry. The summit ensures maximum knowledge transfer among professionals and decision makers to exchange and elaborate on the best practices and explore business partnership opportunities.

KEY TOPICS

EU, US and international regulatory aspects

The use of innovative bio-analytics

Risk management Stratgies for biosimilars

From biosimilars to biogenerics

Numeracy and the Understanding of Clinical Trials with Biosimilars

Biosimilars regulatory affairs

Emerging investment trends and opportunities

Combination products and self-injection devices for biosimilars: Opportunities and pitfalls

Opportunities and pitfall in medical communication for biosimilar products

What can we learn from real life data?

Challenges of Biosimilar Labeling

Establishing “Finger-print Like” Biosimilarity – Critical Characterization Steps for Biosimilar Assessment

Biosimilar insulin, regulatory profile and challenges for gaining marketing authorization approval

Are you on track? – Rapidly evolving regulatory landscape for the development of Biosimilars

The Future of Biosimilars Testing and Development

WHY YOU SHOULD BE HERE?

Network with business development and licensing professionals as well as professionals in your sector

Implement the latest innovations

Learn about the latest technologies and most pressing topics specific to your business

Get an overview on innovative emerging technologies and promote business partnerships within the sector

Interact and connect with leading professionals

Discuss about new opportunities for your products and services with key decision makers

FEATURED SPEAKERS

Cecil Nick

Vice President
PAREXEL International

    Fiona M Greer BSc (Hons) MSc PhD

    Agriculture, Food and Life Global Director, BioPharma Services Development – Life Sciences
    SGS

      Dr. Jakob Lange, Ph.D.

      Account Director
      Ypsomed AG

        Dr. Steinar Madsen

        Medical Director
        Norwegian Medicines Agency

          Uwe Gudat

          Head of Safety, Biosimilars
          Merck

            Fredrik Sundberg

            Global Director, Strategic Market Development
            GE Healthcare

              Grzegorz Orlik, MD

              Head of Medical Affairs, Biosimilars and Generics (Europe)
              Accord Healthcare

              Christian Maasch

              Managing Consultant Product Development and RA
              Xendo Deutschland GmbH

              Chantal LE FLOCH

              Head of GRA-EU-DCV
              Sanofi
                Close

                FEATURED COMPANIES

                SPONSOR

                MEDIA PARTNERS

                REQUEST FORM









                  GREAT OFFERS, RIGHT IN YOUR INBOX!

                  Subscribe to our newsletter and get up-to-date information regarding the ``INTERNATIONAL BIOSIMILARS SUMMIT``

                  Events | Terms and Conditions | Privacy Policy | Cookies Policy | Careers

                  Copyright 2018 © Sharonat Group s.r.o. All rights reserved.

                  Send